Hospira, a provider of injectable drugs and infusion technologies, has introduced the enhanced TheraDoc clinical surveillance system, the TheraDoc system version 4.5, to help hospitals improve patient outcomes and better manage antibiotic use.
The new TheraDoc system version 4.5 is designed to support antimicrobial stewardship programmes and assist with National Healthcare Safety Network (NHSN) reporting and documentation.
Hospira clinical information technology vice president, France Pitera, said the upgraded TheraDoc system helps hospitals leverage patient data to improve antibiotic use, combat antimicrobial resistance and ultimately save lives.
"The software upgrade also helps hospitals improve antimicrobial utilisation reporting - a result of TheraDoc's early work with the CDC on its Antimicrobial Usage Reporting project," Pitera added.
The new version features a new electronic medication administration record (eMAR) interface that integrates medical administration records into the TheraDoc system.
The eMAR interface simplifies the process of isolation management, thereby helping infection preventionists improve patient care.
Other upgrades include an antimicrobial usage dashboard to display medication administration data, antimicrobial alerts to assist clinicians in monitoring therapy duration, identifying de-escalation opportunities and recognising redundant or duplicate therapies.
St Luke's Hospital, Warren Campus, New Jersey, infection preventionist, Lori McSorley, said using the TheraDoc system helps significantly reduce the time it takes for NHSN data collection and reporting.
"Before TheraDoc, it would take ten to 15 minutes per patient to collect and review surgical site infection data before in putting it into the NHSN system," McSorley added.
"Now, information on all of our surgeries, including the start and stop time, class of surgery and patient ASA [physical status] score, can be obtained automatically through the TheraDoc system."
Image: Hospira corporate headquarters in Lake Forest, Illinois, US. Photo courtesy of: Acherubini2020.